Forum LABO Paris 2027

Conferences program

All sessions

The Forum LABO Paris 2027 program is taking shape!

Conferences, feedback sessions, and discussions with experts will explore the innovations, practices, and major challenges shaping the laboratory of tomorrow.

Our ambition: to bring together perspectives from research and industry to provide you with useful insights and practical solutions.

Discover the first sessions and check back regularly for updates.

Mar 23Mar 24Mar 25
Agora
Mar 24, 2027
3:00 PM3:45 PM
Biotechnology, science and healthcare of tomorrow

SFM

Description
Microbiology, antimicrobial resistance and the One Health approach
Agora
Mar 24, 2027
4:00 PM4:45 PM
Industry & materials

ELRIGfr

Description
More information coming soon
Atelier Exposant - Salle 2
Mar 24, 2027
4:15 PM4:45 PM
Industry & materialsInnovation and scientific valorization

De la cellule au métabolite : une approche intégrée pour explorer le métabolisme cellulaire

Description
This DemoLab session offers a complete analytical workflow, from cell characterization to metabolomic analysis. Through a case study, we will show how to combine cell counting and characterization, functional analysis of cellular metabolism, followed by sample preparation and LC-MS analysis to further investigate metabolites. This integrated approach illustrates the complementarity of technologies, enabling a gradual progression from observing the cell to gaining a deeper understanding of its metabolism.
Salle Marie Curie
Mar 25, 2027
10:00 AM10:45 AM
Biotechnology, science and healthcare of tomorrow

FRANCE BIOLEAD

Description
More information coming soon
Agora
Mar 25, 2027
10:00 AM10:45 AM
Industry & materials

GFP Matériaux

Description
More information coming soon
Atelier Exposant - Salle 2
Mar 25, 2027
11:00 AM11:30 AM
Laboratory transformationTransition & regulationIndustry & materialsInnovation and scientific valorization

Agents IA, aide à la formulation, planification intelligence… Entre promesses et réglementations : comment exploiter concrètement l'IA en laboratoire ?

Description
Artificial intelligence is generating as much enthusiasm as it is raising legitimate questions within laboratories. For good reason: R&D and Quality Control teams are balancing the productivity opportunities offered by AI with their day-to-day regulatory requirements (ISO 17025, GxP, etc.) and compliance with the very recent European regulation, the EU AI Act. This session offers a practical overview of how AI is actually being used in the field, by examining business use cases in light of this regulatory challenge, with a particular focus on the EU AI Act. Through this presentation, participants will discover: 1. The new regulatory framework of the EU AI Act: understanding the impact of the new European AI Act regulation on artificial intelligence solutions used in laboratories, including transparency obligations, the essential role of human oversight (human-in-the-loop), and traceability requirements. 2. Managing the quality and relevance of AI-generated results: how to structure databases to provide artificial intelligence with a solid foundation and high-quality data so that it can produce reliable and actionable results. 3. Concrete and operational AI use cases in laboratories: from AI-assisted formulation to intelligent planning, including the automatic extraction of data from documents (scans, PDFs, reports) and natural language support through virtual assistants.
Agora
Mar 25, 2027
11:00 AM11:45 AM
Industry & materials

Implement monitoring methods to optimize your processes – the example of weighing

Description
How can you implement effective process monitoring to better control your operations and prevent non-conformities? This conference will explore the various monitoring methods used in metrology, with a particular focus on internal and external approaches such as control charts and interlaboratory comparisons (ILCs). Using the concrete example of weighing and drawing on our speaker’s experience, we will look at how to rely on recognized methods or approaches tailored to specific needs. We will cover the key criteria to consider when defining maximum permissible errors (MPEs) and determining relevant control frequencies, depending on uses and associated risks. The objective is to provide practical guidance for building an appropriate monitoring strategy. We will conclude with an overview of best practices for using weighing instruments, which are essential to ensuring the quality of day-to-day results.
Salle Marie Curie
Mar 25, 2027
11:00 AM11:45 AM
Biotechnology, science and healthcare of tomorrow

POLEPHARMA

Description
More information coming soon
Agora
Mar 25, 2027
12:00 PM12:45 PM
Biotechnology, science and healthcare of tomorrow

FRANCE BIOVALLEY

Description
More information coming soon
Atelier Exposant - Salle 2
Mar 25, 2027
12:00 PM12:30 PM

SERLABO

Description
More info to come
Atelier Exposant - Salle 2
Mar 25, 2027
1:00 PM1:30 PM

Evolving Regulatory Requirements and the European Pharmacopoeia: Supporting GLP/GMP Laboratories in Their Analytical Practices – LAB DÉMO

Description
Changes to the European Pharmacopoeia and regulatory landscape are encouraging GLP/GMP laboratories to adopt more modern, sustainable methods while continuing to demonstrate assay performance, data integrity and traceability. In this presentation, Molecular Devices will explore how SpectraMax® microplate readers, cellular imaging technologies and SoftMax® Pro software can support laboratories as methods and regulatory expectations evolve. Through practical examples, we will look at four key areas: Pyrogen and endotoxin detection Discover how SpectraMax® readers and SoftMax® Pro can support kinetic chromogenic and turbidimetric LAL assays, recombinant Factor C (rFC) assays and the Monocyte Activation Test (MAT), helping laboratories transition towards modern and animal-free testing approaches. Cellular imaging in regulated laboratories See how combining quantitative results with visual assessment of cell populations can provide greater insight into assay performance, with applications including potency assays and batch-release testing. We will also consider how imaging can be integrated into GMP/GLP workflows while supporting data integrity and traceability. Demonstrating equivalence during method transfer Moving an established method between instruments or laboratories requires confidence that results remain comparable. We will explore an approach to evaluating and documenting equivalence within predefined, scientifically justified limits. Statistical evaluation of regression models Learn how statistical tools, including analysis of variance (ANOVA), can help assess model suitability and dose-dependent responses, and how these evaluations can be incorporated into routine analysis using SoftMax® Pro software. Attendees will gain practical insight into how modern detection, imaging and analysis technologies can help laboratories respond to evolving European Pharmacopoeia expectations while maintaining reliable results, robust methods and traceable data.
Salle Marie Curie
Mar 25, 2027
2:00 PM3:00 PM

IRCGN

Description
More information coming soon
42 sessions
1